ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

BENISE WILLIAMS M.D.

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,987Medicare Part D Prescriptions Filled, Including Refills

Rank: 116 out of 1677

$709K Total Retail Price of All Prescriptions

Rank: 175 out of 1677

703 Patients Receiving at Least One Drug in Part D
58%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 703 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

45% of this provider’s 703 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 9,437 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
HYDROCODONE-ACETAMINOPHEN 1,019 422 S3 1 4
AMLODIPINE BESYLATE 659 407 2 2
FUROSEMIDE 448 351 3 8
FLUCONAZOLE 423 219 10 4 127
OMEPRAZOLE 422 246 5 6
LEVOFLOXACIN 392 188 6 84
LEVOTHYROXINE SODIUM 345 217 7 5
METFORMIN HCL 345 189 7 7
SIMVASTATIN 331 263 9 1
ZOLPIDEM TARTRATE 326 137 10 15
LISINOPRIL 309 174 11 3
LOSARTAN-HYDROCHLOROTHIAZIDE 295 202 12 42
METOPROLOL TARTRATE 242 148 13 12
METOPROLOL SUCCINATE 225 123 14 23
CARVEDILOL 221 163 15 20
POTASSIUM CHLORIDE 218 177 16 14
LOSARTAN POTASSIUM 216 122 17 25
MELOXICAM 215 121 18 27
GABAPENTIN 204 79 19 11
HYDROCHLOROTHIAZIDE 188 109 20 9
ATENOLOL 187 125 21 21
PRAVASTATIN SODIUM 171 129 22 10
NEXIUM 165 84 23 19
METFORMIN HCL ER 164 118 24 51
CARISOPRODOL 162 24 R 25 68
DIOVAN HCT 151 125 26 66
CLONIDINE HCL 149 102 27 36
FLUTICASONE PROPIONATE 123 50 28 29
ALLOPURINOL 123 95 28 31
DIOVAN 117 93 30 45
AZITHROMYCIN 117 68 30 38
RANITIDINE HCL 107 77 32 18
LISINOPRIL-HYDROCHLOROTHIAZIDE 107 45 32 17
ATENOLOL-CHLORTHALIDONE 106 74 34 159
CITALOPRAM HBR 105 89 35 22
KLOR-CON 10 104 79 36 106
AMOXICILLIN 103 68 37 94
PROAIR HFA 96 39 38 50
BENAZEPRIL HCL 94 35 39 53
WARFARIN SODIUM 93 75 40 24
TRAMADOL HCL 90 52 41 16
CLARITHROMYCIN 89 57 42 426
PANTOPRAZOLE SODIUM 88 49 43 46
GLIMEPIRIDE 88 62 43 33
LANTUS 84 48 45 44
PREDNISONE 83 46 46 40
INSULIN SYRINGE 83 47 46 72
ATORVASTATIN CALCIUM 83 36 46 13
TRIAMTERENE-HCTZ 81 33 49 61
KLOR-CON M20 80 69 50 65
METOLAZONE 78 60 51 205
SINGULAIR 78 47 51 97
TRAMADOL HCL-ACETAMINOPHEN 76 47 53 161
HYDRALAZINE HCL 75 71 54 69
NAMENDA 75 75 54 39
OXYCODONE HCL-ACETAMINOPHEN 75 21 S2 54 115
GLYBURIDE-METFORMIN HCL 74 36 R 57 121
CLOTRIMAZOLE-BETAMETHASONE 69 21 58 166
GLIPIZIDE ER 69 37 58 78
PROMETHAZINE HCL 68 36 R 60 64
TRIAMTERENE-HYDROCHLOROTHIAZID 65 49 61 213
PLAVIX 64 42 62 47
BENICAR HCT 64 56 62 194
LUNESTA 64 39 62 260
VALACYCLOVIR 62 31 65 350
FLUOXETINE HCL 60 14 66 49
NOVOLIN 70-30 59 17 67 155
HYDROXYZINE HCL 59 40 R 67 148
ADVAIR DISKUS 56 38 69 54
CYMBALTA 55 13 70 58
BUPROPION XL 55 34 70 165
MONTELUKAST SODIUM 53 34 72 174
LOVASTATIN 51 38 73 35
MECLIZINE HCL 51 38 73 110
ACETAMINOPHEN-CODEINE 51 39 S3 73 136
AMLODIPINE BESYLATE-BENAZEPRIL 50 40 76 59
FAMOTIDINE 50 21 76 41
GLIPIZIDE 50 31 76 56
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.